Previous studies in human beings on unrestricted diets have indicated that the plant sterols (beta or gamma sitosterol) cause decreases in serum cholesterol. In this study, 15 young men with previous mvocardial infarction were given 12 to 18 Gm./day of beta sitosterol with resultant sustained reductions of serum cholesterol and beta lipoprotein lipid. Lipoprotein lipid fractionation was performed by paper electrophoresis. These changes occurred irrespective of initial serum cholesterol or content of diet. Control observations of the effects of diet, weight maintenance, and the inclusion of placebos brought about increased confidence that the changes were due to the administeredl sitosterol.
T HE search for agents capable of modifying the serum lipids of man was stimulated by the observation of Peterson in 19511 that the usual hypercholesterolemia of chicks fed cholesterol-enriched diets was prevented by the addition of plant sterols to the diet. In a similar study, Pollak2 described the same phenomenon in rabbits. Hernandez and Chaikoff3 found that the recovery of C14 labeled cholesterol from the thoracic duct of cholesterol-fed rats was substantially reduced by the addition of as little as 4 mg. of sitosterols to a meal containing 100 mg. of cholesterol. Subsequent investigators have reported decreases in serum cholesterol in normal and hypercholesterolemic human beings given varying doses of the plant sterols, gamma and beta sitosterols. [4] [5] [6] More recently, Best and co-workers7 reported decreases in serum phospholipid, cholesterol, total lipid, and Sf3-l00 lipoproteins after beta sitosterol administration. The reductions in phospholipid and lipoproteins were less consistent and less marked than the changes in serum cholesterol and total lipid. The No placebo periods were included in their study.
This study was undertaken to evaluate the effects of 0-sitosterol on the serum lipids in patients with arteriosclerotic heart disease, with careful attention to the control of diet, weight, and activity variables.
METHODS AND MATERIALS
Fifteen normotensive, nondiabetic men between the ages of 26 and 45, who had sustained previous well documented myocardial infarction, were studied with serial serum lipid determinations during a 3-phase study: (1) a premedication period of 6 to 12 weeks, (2) a period of sitosterol administration of 12 to 24 weeks, (3) a period of placebo administration of 10 to 16 weeks.
The placebo preparation was similar in taste and appearance to the sitosterol and none of the patients were aware of the change.
Prior to the first phase of the study all patients were placed on diets designed to maintain constant weight. The per cent of calories from fat was from 23 to 28 per cent in 9 patients and from 40 to 48 per cent in 6 patients. With the exception of 1 patient who lost 8 pounds during the first phase, the weights of all the patients were maintained to within 3 pounds of their initial values.
Cholesterol intake was from 200 to 300 mg./day in the 9 patients on fat-restricted diets and 900 toBETA SITOSTEROL AND SERUM LIPIDS IN ARTERIOSCLEROSIS or vegetable sources, but the proportions of these types of fat did not vary much since all patients followed their prescribed diets.
Thren equal portions of f3-sitosterol* were given * Supplied by Eli Lilly and Company, Indianapolis, Ind.
orally immediately before meals in total amounts of 12 to 18 Gm./day. During all phases of the study the patients were ambulatory, and efforts were made to achieve a "steady state" in respect to exercise, diet, and body weight.
Fifteen apparently normal men matched for age with the 15 study patients had serum lipid measurements for comparative baseline studies.
Serum was obtained in the fasting state at weekly or biweekly intervals during all phases. Serum was analyzed for cholesterol by the method of Abell,9 total lipid by the method of Swahn,10 and lipoprotein lipid calculated by protein and lipid staining of paper strips separated by electrophoresis. The electrophoresis was performed in an apparatus similar to that described by Durrum and associates,"1 using 6 35 cm. by 2.5 cm. Whatman 3 MM.t strips run for It has been adequately proved that sitosterols lower the serum cholesterol of man,5-7 and prevent increases in liver and plasma cholesterol of laboratory animals fed diets high in cholesterol." 2, 13-15 However, the mechanisms of these actions are unknown. An attractive postulate is that sitosterol competes with cholesterol for available fatty acids, bile salts, and the enzyme used in cholesterol esterification, thereby interfering with cholesterol absorption.7' 14 Swell and co-workers14 have shown that soy sterols are esterified in vitro in the presence of pancreatic cholesterol esterase, the rate of esterification being only slightly less than that of cholesterol. In contrast to the action of free sitosterol, Best, Duncan, and Wathenl6 have found that sitosterol esters do not prevent increases in tissue lipids in myxedematous rats. This latter finding furnishes indirect support for the hypothesis that sitosterol acts by interfering with esterification of cholesterol.
A second postulate of the action of sitosterol is that it combines with cholesterol in the gut to form a more stable, less absorbable complex.2 This union may be similar to that complex formed in the Liebermann-Burchard reaction between cholesterol and digitonin, another sterol.
Either postulate assumes inhibition of absorption of both dietary cholesterol and that portion of endogenous cholesterol excreted in the bile. Since both dietary and biliary cholesterol are predominantly in the free form, there is no reason to believe sitosterol would differentiate between them.
Although studies to date would indicate that sitosterol acts on cholesterol absorption, further work is needed to determine its relationship to the transport, metabolism, and excretion of cholesterol and lipoproteins. In iste gruppo anormal, le administration de beta-sitosterol resultava in significativissime reductiones del cholesterol seral e del lipido beta-lipoproteinic, accompaniate de minus marcate reductiones de lipido total e un leve augmento del lipido alpha-lipoproteinic.
Le apparente absentia de effectos noeive, insimul con le supra-mentionate alterationes, indica possibilemente que le administration de sitosterol resulta in effectos benefic. Le rolo de sitosterol como agente therapeutic in le medicine clinic es non ancora establite.
the coronary lesions are due in part to intravascular stress caused by the hemodynamics of the coronary circulation, as modified by anatomic factors. The stress results in subendothelial fibroblastic proliferation, deposition of a mucoid ground substance, and fragmentation of the internal elastic membrane. It is of interest to compare the lesions found in the American soldiers with the lesions found in a small series of Japanese natives now being studied. Thirty Japanese men, approximating the age group of the American soliders, were found in material from 114 cases studied in Japan. The amount and distribution of the lipids on the elastica and within the parenchyma of the plaques found in the Americans, as compared to the Japanese, indicate that certain plasma lipids, as modified by diet, are another important agent in the development of coronary disease in young males. KITCHELL 
